Effect of ouabain on amino acid uptake by mouse ascites-tumour cells in the presence of nigericin.
Mouse ascites-tumour cells oxidizing lactate, in a modified Ringer solution, concentrated 2-aminoisobutyrate, L-methionine or 2-(methylamino)isobutyrate about 20-fold from a 0.4 mM solution in the presence of 2-3 micrograms of nigericin/mg cellular dry wt. The ionophore increased cellular [Na+] to almost 100 mM when extracellular [Na+] was about 45 mM. Either valinomycin or the two mitochondrial inhibitors oligomycin and antimycin acting together each markedly lowered the extent to which the tumour cells concentrated amino acid, from the above factor of about 20 to roughly 2-fold. Ouabain (1 mM) had a similar effect, and further raised cellular [Na+]. The sodium pump appeared to be closely involved in amino acid uptake under these conditions.
D000596:Amino Acids / Q000378:metabolism*; D000621:Aminoisobutyric Acids / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000968:Antimycin A / Q000031:analogs & derivatives / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D066298:In Vitro Techniques; D051379:Mice; D009550:Nigericin / Q000494:pharmacology*; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism; D012709:Serum Albumin / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D014634:Valinomycin / Q000494:pharmacology
D000596:Amino Acids; D000621:Aminoisobutyric Acids; D000900:Anti-Bacterial Agents; D009840:Oligomycins; D012709:Serum Albumin; C032456:antimycin; C100049:2-aminoisobutyric acid; D014634:Valinomycin; D010042:Ouabain; D000968:Antimycin A; D012964:Sodium; D009550:Nigericin; D011188:Potassium